IWONA PRABUCKA-DAVIS: Open Payments
NPI 1518596642 · AUBURN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 33 payments from 8 companies in 2025. Trend: 2023 $1,352 · 2024 $1,098 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $206 |
| Lilly USA, LLC | 5 | $119 |
| Sumitomo Pharma America, Inc. | 5 | $87 |
| Novo Nordisk Inc | 3 | $61 |
| Ardelyx, Inc. | 3 | $52 |
| Exact Sciences Corporation | 3 | $51 |
| Hologic Sales and Service, LLC | 1 | $27 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
Products named: LINZESS, MOUNJARO, GEMTESA, UBRELVY, IBSRELA, The Cologuard Plus Collection Kit, Wegovy, ZEPBOUND.
Industry payments across MA — which companies pay providers there.
